医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Terns Pharmaceuticals to Present at BioCentury’s 26th Annual Future Leaders in Biotech Industry Conference

2019年04月08日 PM06:00
このエントリーをはてなブックマークに追加


 

SAN MATEO, Calif. & SHANGHAI

Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly targeted, oral, small-molecule drugs to treat NASH and cancer, today announced that Randy Halcomb, Ph.D., senior vice president of chemistry and early development, will present a corporate overview and update on the Company’s lead programs at BioCentury’s 26th Annual Future Leaders in the Biotech Industry Conference on Friday, April 12, 2018 at 2pm Eastern Time in room 404/405. The conference is being held at the Millennium Broadway Hotel in New York City.

About Terns Pharmaceuticals

Terns Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that is focused on the discovery and development of medicines for chronic liver disease and cancer. Based in China and the United States, the company is advancing a pipeline of small molecule drug candidates for the treatment of non-alcoholic steatohepatitis (NASH) and cancer, across multiple modalities. Terns leverages world class expertise in disease biology, medicinal chemistry, and clinical development, in order to bring promising new therapies to patients in China and other global markets.

For more information, visit www.ternspharma.com and www.ternspharma.com.cn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190408005272/en/

CONTACT

US Media Contact:
Margaret Robinson
(415) 690-0084

China Media Contact:
Xia Zou
+86 18523948668

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Seoul Viosys’ Violeds Modules Proven to Disinfect 99% of Airborne Viruses in a Recent Testing Result
  • Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan
  • Kaye推出适用于冷链运输市场的Kaye® Log -80℃ 疫苗温度记录器,以满足COVID-19疫苗储存和运输的要求
  • Kaye® (ケイ)は、COVID-19ワクチンの輸送・保管のニーズに応えるためにKaye® ログ -80ワクチン温度ロガーを、コールドチェーン市場向けに導入(発売)します。
  • DNP的新型非接触式透明屏幕可通过手的动作进行操作